Comparison of the TTL in patients with sAML and CML-BC and the OS in the entire cohort. A) The median TTL is significantly shorter in AML-post-MDS (4.80±1.0 months) than in AML-post-MPN (20.3±2.9 months) and the longest in CML-BC (34.7±16.3 months) (Kaplan Meyer log rank test, p=0.008); B) No difference in the OS (Kaplan Meyer log rank test, p=0.355) despite the fact that CML-BC patients (median OS 13.67±4.58 months) tended to have the longest OS compared with the dn-AML-MDS (median OS 6.17±2.77 months) and sAMLs groups (median OS in AML-post-MDS, 4.17±0.7 months; median OS in AML-post-MPN 7 5.17±2.79 months).

 
 
  Part of: Jagurinoski M, Davidkova Y, Stojcov-Jagurinoska M, Balatzenko G, Spassov B, Guenova M (2023) Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers? Folia Medica 65(5): 728-736. https://doi.org/10.3897/folmed.65.e98404